Target cells | Antigenic CD19 sites | Antigenic CD20 sites | EC50GBR 401 (μg/ml) | EC50RTX (μg/ml) | EC50GBR 401 (F) (μg/ml) | Average max killing GBR 401 (%) | Average max killing RTX (%) | Average max killing GBR 401 (F) (%) |
---|---|---|---|---|---|---|---|---|
Raji | 57 100 (11 000) | 100 400 (13 200) | 0.0012 | 0.012# | 0.08# | 80 | 60 | 30# |
Ramos | 50 700 (6700) | 160 600 (29 700) | 0.0009 | 0.016 | Â | 60 | 60 | Â |
SU-DHL-6 | 30 000 (4800) | 822 400 (41 000) | 0.0008 | 0.0045 | Â | 50 | 40 | Â |
Namalwa | 37 900 (4500) | 1 700 (1200) | 0.002 | NA | Â | 60 | 15 | Â |
B-CLL | 10 520 (4140) | 3 230 (2000) | 0.0016 (0.003) | 0.8*** (1.1) | Â | 60.04 (16.9) | 44.54*** (15.1) | Â |
Lymphoma | Â | Â | 0.015 | 0.15** | Â | 32 | 32 | Â |